FILE – A sign for the U.S. Food and Drug Administration is displayed outside their offices in Silver Spring, Md., Dec. 10, 2020. (AP Photo/Manuel Balce Ceneta, File)

...

Gabe Whisnant

By Gabe Whisnant

News Editor

0

Share

Newsweek is a Trust Project member

See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.


U.S. health officials are urging parents and caregivers to check medicine cabinets after a nationwide recall was issued for 4‑fluid‑ounce bottles of Children’s Ibuprofen Oral Suspension, USP, a liquid product labeled 100 milligrams per 5 milliliters.

The Food and Drug Administration (FDA) said the recall follows consumer complaints describing the presence of a foreign substance in the medication, including reports of a gel-like mass and black particles.

Strides Pharma Inc. is recalling 89,592 bottles that were distributed nationwide, according to reporting that cited the FDA’s recall information.

Read More on Life

Why Is there a Recall?

The recall was initiated after the recalling firm received complaints about a gel-like mass and black particles in the children’s ibuprofen product, the FDA said.

The FDA has classified the action as a Class II recall, which the agency defines as a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

The reports did not specify how the foreign material entered the product, and the FDA notice did not provide additional details beyond the complaints cited in the recall listing.

A sign for the U.S. Food and Drug Administration is displayed outside their offices in Silver Spring, Maryland, December 10, 2020.

...

Which Products Lots Were Recalled?

The recall involves Children’s Ibuprofen Oral Suspension, USP, 100 mg per 5mL, sold in 4 FL OZ (120 mL) bottles, according to reports citing the FDA recall.

The affected lots are 7261973A and 7261974A, with an expiration date of January 31, 2027.

The product was manufactured for Taro Pharmaceuticals USA Inc., and the recalled bottles were distributed nationwide, according to the same reports.

What To Do With a Recalled Product

Consumers should stop using any recalled product and check the bottle or packaging for the lot number and expiration date, the FDA guidance cited in reports said.

Parents and caregivers who believe a child may have been affected after taking the recalled medication should contact a health care provider.

Consumers can also report adverse events or quality problems to the FDA through its safety reporting systems, including MedWatch.

A logo sign outside of a facility occupied by Taro Pharmaceutical Industries in Brampton, Ontario, Canada, on April 16, 2017. ( AP Images)

...

View 0 Comments

Request Reprint & Licensing

Submit Correction

View Editorial & AI Guidelines